Approval · Notice of Compliance 32757 · 2024
LOCAMETZ: Notice of Compliance 32757
Issued February 22, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32757
- Date
- February 22, 2024
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOCAMETZ | Not yet assigned | — |
Medicinal ingredients
- GALLIUM (68GA) GOZETOTIDE 25 MCG per VIAL